Cellular Oncology

Papers
(The TQCC of Cellular Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Angiogenesis as a hallmark of solid tumors - clinical perspectives110
Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy78
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities72
Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles68
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN67
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications58
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance51
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications46
Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update46
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma44
Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation40
A comprehensive review of SHP2 and its role in cancer35
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis34
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities31
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment30
HDAC6: A unique HDAC family member as a cancer target29
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers29
Non-coding RNAs underlying chemoresistance in gastric cancer28
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma27
[10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models26
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells26
LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer26
Protein arginine methyltransferase 5: a potential cancer therapeutic target25
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer25
HIF1A expression correlates with increased tumor immune and stromal signatures and aggressive phenotypes in human cancers25
Functional and metabolic targeting of natural killer cells to solid tumors24
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing23
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation23
EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway23
Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression23
The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary22
Clinical perspectives of BET inhibition in ovarian cancer22
The Duchenne muscular dystrophy gene and cancer22
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin22
Circular RNA circNFATC3 acts as a miR-9-5p sponge to promote cervical cancer development by upregulating SDC222
Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity20
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy20
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers19
How VEGF-A and its splice variants affect breast cancer development – clinical implications19
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis19
Cancer‐associated fibroblasts secrete hypoxia‐induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway19
Enhanced immunogenicity of leukemia-derived exosomes via transfection with lentiviral vectors encoding costimulatory molecules19
Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma19
Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma18
Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation18
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications18
Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression18
Molecular mechanisms underlining the role of metformin as a therapeutic agent in lung cancer17
The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis17
LINC02154 promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing SPC24 promoter activity and activating the PI3K-AKT signaling pathway17
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment17
Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging17
A lectin-based glycomic approach identifies FUT8 as a driver of radioresistance in oesophageal squamous cell carcinoma17
RETRACTED ARTICLE: Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis17
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer17
Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A16
Long non‐coding RNA LINC01137 contributes to oral squamous cell carcinoma development and is negatively regulated by miR-22-3p16
Sp1-mediated up-regulation of lnc00152 promotes invasion and metastasis of retinoblastoma cells via the miR-30d/SOX9/ZEB2 pathway16
LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity16
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling16
Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer15
Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction15
Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity15
SIRT7 interacts with TEK (TIE2) to promote adriamycin induced metastasis in breast cancer15
Comprehensive analysis of cytoskeleton regulatory genes identifies ezrin as a prognostic marker and molecular target in acute myeloid leukemia15
Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel15
Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer15
The impact of mitochondria on cancer treatment resistance15
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer15
RETRACTED ARTICLE: IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling15
Organoid technology for personalized pancreatic cancer therapy14
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening14
1p/19q co-deletion status is associated with distinct tumor-associated macrophage infiltration in IDH mutated lower-grade gliomas14
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers14
Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress14
LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA614
Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer14
The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models14
Epithelial-stromal communication via CXCL1-CXCR2 interaction stimulates growth of ovarian cancer cells through p38 activation14
RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer14
UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells13
Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion13
Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway13
Bile acids increase intestinal marker expression via the FXR/SNAI2/miR-1 axis in the stomach13
Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer13
Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy12
IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer12
The application of patient-derived organoid in the research of lung cancer12
Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis12
SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α12
Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor12
Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition12
Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m6A demethylation of EIF4EBP1 and MLST8 mRNA12
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets11
Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation11
Downregulation of beta-catenin in chemo-tolerant TNBC through changes in receptor and antagonist profiles of the WNT pathway: Clinical and prognostic implications11
Blocking MMP-12-modulated epithelial-mesenchymal transition by repurposing penfluridol restrains lung adenocarcinoma metastasis via uPA/uPAR/TGF-β/Akt pathway11
FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer11
The role of pyroptosis in hepatocellular carcinoma11
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models11
Role of the bone microenvironment in bone metastasis of malignant tumors - therapeutic implications11
Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma10
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy10
Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma10
Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS10
PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer10
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer10
NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells10
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells9
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer9
Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB9
BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways9
Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial–mesenchymal transition through targeting major vault protein (MVP)9
GAS41 mediates proliferation and GEM chemoresistance via H2A.Z.2 and Notch1 in pancreatic cancer9
Crosstalk between oxidative phosphorylation and immune escape in cancer: a new concept of therapeutic targets selection9
Aberrantly expressed Bruton’s tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells9
In-depth quantitative proteomics analysis revealed C1GALT1 depletion in ECC-1 cells mimics an aggressive endometrial cancer phenotype observed in cancer patients with low C1GALT1 expression9
CD105 is a prognostic marker and valid endothelial target for microbubble platforms in cholangiocarcinoma9
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination9
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma9
The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma9
0.080639123916626